Meat consumption sits at the center of this dementia and brain health question.

A new Swedish study published in JAMA Network Open suggests that people genetically predisposed to Alzheimer’s disease may experience slower cognitive decline and lower dementia risk when consuming higher amounts of unprocessed meat. Researchers following over 2,100 Swedish adults for 15 years found that individuals carrying APOE 3/4 or APOE 4/4 gene variants—which account for roughly 70% of Alzheimer’s cases—showed significantly better cognitive outcomes on a meat-rich diet. This finding stands in stark contrast to what many dementia prevention frameworks have suggested, making it a notable shift in how we understand genetic risk, diet, and brain health.

The research, led by Jakob Norgren and colleagues at Karolinska Institutet, focused specifically on unprocessed meat consumption. An important distinction that cannot be overlooked: processed meats showed the opposite effect, linking to higher dementia risk regardless of genetic status. This article explores what the study reveals about APOE carriers and meat, why the gene-diet interaction matters, and how these findings might—or might not—apply to your own situation.

What Is the APOE Gene and Why Does It Matter for Dementia Risk?
Unprocessed Meat vs. Processed Meat—A Critical Distinction
The Evolutionary Hypothesis—Why APOE 4 Carriers Might Benefit from Meat
Practical Dietary Implications for APOE 4 Carriers
Important Limitations—What This Study Cannot Tell Us
What About APOE 2 and APOE 3 Carriers?
Where Does This Fit in the Broader Dementia Prevention Landscape?
Conclusion

What Is the APOE Gene and Why Does It Matter for Dementia Risk?

The APOE gene comes in three main variants: APOE 2, APOE 3, and APOE 4. The combinations matter: someone can carry two copies of the same variant (homozygous) or one of each (heterozygous). The APOE 4 variant is particularly significant for Alzheimer’s risk. Among the Swedish population, approximately 30% carry either APOE 3/4 (one copy of APOE 4) or APOE 4/4 (two copies of APOE 4) genotypes.

What makes this relevant to dementia is stark: among people who develop Alzheimer’s disease, carriers of these APOE 4-containing genotypes account for nearly 70% of cases. This doesn’t mean everyone with APOE 3/4 or 4/4 will develop dementia—many won’t—but the genetic predisposition significantly elevates risk. Previous research has shown that APOE 4 carriers have higher brain amyloid accumulation (a hallmark of Alzheimer’s pathology) even decades before symptoms appear. The APOE 3/3 combination, by contrast, is considered relatively protective.

What Is the APOE Gene and Why Does It Matter for Dementia Risk?

Unprocessed Meat vs. Processed Meat—A Critical Distinction

This is where the Karolinska study introduces an unexpected wrinkle in dietary guidance. The researchers found that higher consumption of unprocessed meat—think fresh beef, pork, poultry, and fish—was associated with slower cognitive decline and lower dementia risk specifically in APOE 3/4 and 4/4 carriers. However, processed meats told a completely different story. Higher consumption of processed meats (deli meats, sausages, bacon, processed ham) was linked to higher dementia risk across the entire population, regardless of genetics.

This distinction is crucial because many studies on “meat and dementia” lump all meat together, leading to confusing or contradictory headlines. For someone with the genetic predisposition, the type of meat may determine whether they see protective benefits or increased harm. The mechanistic reason likely relates to additives in processed meats—nitrates, excess sodium, and various preservatives—which carry independent neuroinflammatory risks. Unprocessed meat, by contrast, provides bioavailable nutrients and proteins without these chemical additions.

The Evolutionary Hypothesis—Why APOE 4 Carriers Might Benefit from Meat

The mechanistic hypothesis proposed by the Karolinska researchers offers a compelling evolutionary explanation. APOE 4 is the evolutionarily oldest variant, having emerged when human ancestors consumed predominantly animal-based diets before agriculture became widespread. The thinking goes: APOE 4 carriers may retain metabolic adaptations that favor meat-based nutrition. Their ancestors survived and reproduced on meat-heavy diets, and their metabolism may still reflect those ancestral conditions.

This is not to say APOE 4 carriers need meat to survive or thrive in modern contexts, but rather that their particular genetic variant evolved in an environment where animal protein and fat were primary nutritional sources. In modern times, an APOE 4 carrier might experience a mismatch between their genetic predispositions and a very low-fat, plant-heavy diet. By contrast, APOE 3 and APOE 2 carriers represent later evolutionary adaptations to more varied diets, and their metabolism may handle a broader range of nutritional patterns. This hypothesis aligns with growing evidence that “personalized nutrition” based on genetics may be more effective than one-size-fits-all dietary recommendations.

The Evolutionary Hypothesis—Why APOE 4 Carriers Might Benefit from Meat

Practical Dietary Implications for APOE 4 Carriers

If you carry the APOE 3/4 or 4/4 genotype, this research suggests that avoiding aggressive low-fat, very high-carbohydrate diets in favor of adequate unprocessed meat intake may benefit cognitive health. A practical approach might involve consuming unprocessed red meat, poultry, and fish 3–5 times per week, rather than treating meat as a rare treat or eliminating it entirely. This contrasts sharply with some dementia-prevention diets (like strict versions of the MIND diet) that prioritize plant foods and minimize all meat.

However, this does not mean APOE 4 carriers should overeat meat indiscriminately or ignore other dementia risk factors like cardiovascular health, physical inactivity, and cognitive engagement. Unprocessed meat is nutrient-dense but also calorie-dense; portion control remains important. Someone with APOE 3/4 who is overweight, has hypertension, or has poor cholesterol profiles might not experience cognitive benefits from meat if metabolic disease is driving neuroinflammation. The point is that meat, specifically unprocessed varieties, appears to be a neutral or beneficial food for this genetic subgroup—not something to fear or avoid based on genetic risk alone.

Important Limitations—What This Study Cannot Tell Us

The Karolinska study is observational, not a randomized controlled trial. This is a fundamental limitation. The researchers followed people’s existing dietary patterns and compared cognition; they did not assign some people to eat meat and others to avoid it. This means we cannot yet prove that meat *causes* the protective effect—only that it correlates with better outcomes in APOE carriers. Other unmeasured factors (overall health, exercise, wealth, access to fresh foods, family support) could explain the association.

Additionally, the study was conducted in Sweden, a population with specific genetic ancestry, healthcare systems, and dietary traditions. Results may not generalize identically to other populations, particularly those with different ancestral proportions of APOE variants. A Japanese population, an African population, or a Latino population might show different patterns. The study also measured cognitive outcomes via self-report and brief cognitive testing, not comprehensive neuroimaging or biomarker assessments. To definitively establish that meat protects cognition in APOE 4 carriers, researchers would need to conduct randomized intervention trials, which are expensive and slow to produce results.

Important Limitations—What This Study Cannot Tell Us

What About APOE 2 and APOE 3 Carriers?

For people who carry APOE 3/3 or other non-4 combinations, the message is less clear from this study. The Karolinska research focused specifically on APOE 4 carriers and their cognitive outcomes on different diets. They did not report detailed results for APOE 2 or APOE 3/3 groups eating varying meat amounts.

Generally speaking, these individuals have lower baseline Alzheimer’s risk, so their dietary choices may matter less for genetic reasons and more for overall health (cardiovascular, metabolic, inflammatory status). That said, the observational association between processed meat consumption and higher dementia risk applied to the entire population studied, not just APOE 4 carriers. This suggests that regardless of your genotype, minimizing processed meats and preferring unprocessed options remains sound advice for brain health. For non-APOE 4 carriers, dementia prevention likely depends more on factors like cognitive engagement, physical activity, cardiovascular health, and overall diet quality than on meat consumption specifically.

Where Does This Fit in the Broader Dementia Prevention Landscape?

This study is part of a growing trend toward precision or personalized nutrition in dementia research. Rather than recommending one diet for all—”everyone should eat Mediterranean,” or “everyone should avoid red meat”—researchers increasingly recognize that genetics, ancestry, and individual metabolic profiles influence which dietary patterns prevent cognitive decline. The APOE genotype is becoming a more common consideration in clinical practice, particularly among people with a family history of Alzheimer’s.

Looking forward, the next phase of research should include randomized controlled trials testing whether APOE 4 carriers who increase unprocessed meat intake actually show slower cognitive decline compared to those on plant-based or lower-meat diets. Simultaneously, mechanistic studies could identify the specific nutrients or metabolic pathways through which unprocessed meat might benefit APOE 4 cognition. This might reveal that it’s not meat per se, but certain nutrients abundant in meat (iron, B12, choline, carnitine) that drive the effect. Such findings could eventually lead to personalized dietary recommendations or even supplements tailored to genotype.

Conclusion

The Karolinska Institutet study provides evidence that people with genetic predisposition to Alzheimer’s disease—specifically APOE 3/4 and 4/4 carriers—may experience cognitive benefits from consuming adequate amounts of unprocessed meat. This finding challenges the notion that meat consumption universally increases dementia risk and instead suggests a gene-diet interaction: what’s optimal for one genetic group may differ from what’s optimal for another. The critical caveat is that this applies to unprocessed meats; processed meats showed the opposite effect and should be minimized by everyone concerned about dementia risk.

If you have not had your APOE status tested and have a family history of dementia, consulting with your physician about genetic testing may help personalize your dietary approach. If you are an APOE 4 carrier currently avoiding meat based on general dementia-prevention advice, this research suggests you may safely include unprocessed meat as part of your diet without neurological concern—and potentially with cognitive benefit. However, meat is one variable among many; cardiovascular health, exercise, cognitive engagement, sleep quality, and social connection remain equally or more important for long-term brain health.